| Epidermal Dipeptide, EDP | C7H10N2O4 | 186.17 | 29227-88-1 | Pyr-Gly-OH |
| Pyr-Phe-OH | C14H16N2O4 | 276.29 | 21282-12-2 | Pyr-Phe-OH |
| Pyr-Phe-Gly-NH2 | C16H20N4O4 | 332.36 | 203396-25-2 | Pyr-Phe-Gly-NH2 |
| Pyr-Phe-Leu-pNA | C26H31N5O6 | 509.56 | 85901-57-1 | Pyr-Phe-Leu-pNA |
| Pyr-Pro-Arg-pNA | C22H30N8O6 | 502.53 | 72194-57-1 | Pyr-Pro-Arg-pNA |
| Pyr-Val-OH | C10H16N2O4 | 228.25 | 21282-10-0 | Pyr-Val-OH |
| RANTES (human), Small-Inducible Cytokine A5, CCL5, T Cell-Specific Protein P228, TCP228 | C350H534N96O100S5 | 7847.01 | H-Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser-OH (Disulfide bonds between Cys¹⁰ and Cys³⁴/Cys¹¹ and Cys⁵⁰) | |
| Met-RANTES (human) | C355H543N97O101S6 | 7978.21 | H-Met-Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser-OH (Disulfide bonds between Cys¹⁰ and Cys³⁴/Cys¹¹ and Cys⁵⁰) | |
| Acetyl-(Ala10·11)-RANTES (1-14) amide (human) | C69H95N15O24 | 1518.6 | 838825-26-6 | Ac-Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Ala-Ala-Phe-Ala-Tyr-NH2 |
| RANTES (3-68) (human) | C342H522N94O97S5 | 7662.81 | H-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser-OH (Disulfide bonds between Cys¹⁰ and Cys³⁴/Cys¹¹ and Cys⁵⁰) | |
| C52H72N12O10 | 1025.22 | 50410-01-0 | H-His-Pro-Phe-His-Leu-D-Leu-Val-Tyr-OH | |
| PHPFHLFVY | C60H77N13O11 | 1156.35 | H-Pro-His-Pro-Phe-His-Leu-Phe-Val-Tyr-OH | |
| PHPFHFFVYK | C69H87N15O12 | 1318.54 | 75645-19-1 | H-Pro-His-Pro-Phe-His-Phe-Phe-Val-Tyr-Lys-OH |
| C72H110N20O15 | 1495.79 | 93287-54-8 | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-Ome | |
| C30H38N4O6 | 550.66 | 76524-85-1 | H-Leu-Val-Tyr-AMC | |
| Preangiotensinogen (11-14) (human) | C21H35N7O6 | 481.55 | 102813-98-9 | H-Val-Ile-His-Asn-OH |
| Acetyl-Tetradecapeptide Renin Substrate (horse), Acetyl-Angiotensinogen (1-14) (horse), Acetyl-Preangiotensinogen (1-14) (horse) | C87H125N21O21 | 1801.08 | 66641-26-7 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
| Acetyl-Tetradecapeptide Renin Substrate (human), Acetyl-Angiotensinogen (1-14) (human), Acetyl-Preangiotensinogen (1-14) (human) | C85H124N24O20 | 1802.07 | 104180-27-0 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn-OH |
| Tetradecapeptide Renin Substrate (rat), Angiotensinogen (1-14) (rat), Preangiotensinogen (1-14) (rat) | C89H123N21O21 | 1823.08 | 110200-37-8 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser-OH |
| Tetradecapeptide Renin Substrate (horse), Angiotensinogen (1-14) (horse), Preangiotensinogen (1-14) (horse) | C85H123N21O20 | 1759.04 | 20845-02-7 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
